Skip to main content
. 2024 Feb 28;18:1675. doi: 10.3332/ecancer.2024.1675

Table 3. Cost per DALY averted: base case and sensitivity analysis.

Life expectancy (LE)a and late-effect morbidity scenario Discounting
0% 3% 6%
Base case (Normal LE, no utility adjustment for late-effect morbidity) $537b $1,128b $1,920c
Normal LE + utility adjustment for late effect morbidity $567b $1,151b $1,932c
15% Reduction in LE + utility adjustment for late-effect morbidity $678b $1,243b $1,986c
30% Reduction in LE + utility adjustment for late-effect morbidity $845b $1,388b $2,087c
a

Decrements in life expectancy selected based on Yeh et al [25]

b

Very cost-effective

c

Cost-effective